非磺脲类降糖药的研究现状与临床评价

非磺脲类降糖药的研究现状与临床评价

作者：张石革， 宋菲， Zhang Shige， SONG Fei

作者单位：北京大学北京积水潭医院,北京市,100035

刊名：

中国医院用药评价与分析

英文刊名：EVALUATION AND ANALYSIS OF DRUG-USE IN HOSPITALS OF CHINA

年，卷(期)：2005,5(1)

被引用次数：1次

参考文献(20条)

1.Hu S;Boettcher BR;Dunning BE The mechanisms underlying the unique pharmacodynamics of nateglinide [外文期刊] 2003(z1)

2.Gregorio F;Ambrosi F;Boemi M Effects of S 21403 on hormone secretion from isolated rat pancreas at different glucose concentrations[外文期刊] 2002(13)

3.McLeod JF Clinical pharmacokinetics of nateglinide:a rapidly- absorbed,short - acting insulinotropic agent 2004(02)

4.Anderson D;Shelley S;Kellett N The effect of nateglinide taken with food on gastric emptying rates in healthy subjects[外文期刊] 2003(06)

5.Sunaga Y;Gonoi T;Shibasaki T The effects of mitiglinide (KAD - 1229),a new anti - diabetic drug,on ATP- sensitive K channels and insulin secretion:comparison with the sulfonylureas and nateglinide 2001(01)

6.Gribble FM;Reimann F Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions[外文期刊] 2003(02)

7.Moses R Repaglinide in combination therapy 2002(6)

8.Horton ES;Clinkingbeard C;Gatlin M Nateglinide alone and in combination with metformin improves glyeemie control by reducing mealtime glucose levels in type 2 diabetes[外文期刊] 2000(11)

9.Slas Andrade S;Revilla Monsalve MC;Martinez de Hurtado E Evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus:a multicenter, multinational, non- randomized, non- controlled Latin American study[外文期刊] 2003(02)

10.Hollander P;Schwarz S;Gatlin M Importance of early insulin secretion:Comparison of nateglinide and glyburide in previously diet - treated patients with type 2 diabetes[外文期刊] 2001(6)

11.McLeod JF Clinical pharmacokinetics of nateglinide: a rapidly- absorbed, short- acting insulinotropic agent 2004(02)

12.Unkara G;Bigler H;WangY The effect of nateglinide on the pharmacokineties and pharmacodynamics of aeenocoumarol[外文期刊] 2004(01)

13.Devineni D;Walter YH;Smith HT Pharmacokinetics of nateglinide in renally impaired diabetic patients 2003(02)

14.Phillips LS;Dunning BE Nateglinide ( starlix ): update on a new antidiabetic agent 2003(06)

15.Caro J J;Salas M;O' Brien JA Modeling the efficiency of reaching a target intermediate end point:a case study in type 2 diabetes in the United States 2004(01)

16.Reimann F;Proks P;Ashcroft FM Effects of mitiglinide (S21403) on Kir6.2/SUR1, Kir6.2/SUR2A and

Kir6.2/SUR2B types of ATP- sensitive potassium channel[外文期刊] 2001(07)

17.Buse JB;Tan MH;Prince M J The effects of oral antihyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes[外文期刊] 2004(02)

18.Odawara M Nateglinide and mitiglinide[外文期刊] 2003(07)

19.Plosker GL;Figgitt DP Repaglinide:a pharmacoeconomic review of its use in type 2 diabetes

mellitus 2004(06)

20.Malaisse WJ Analogues du meglitinide: nouveaux agents insuliuotropes pour le traitement du diabete non - insulinodependant. Meglitinide analogs: new insulinotropic agents for the treatment of non - insulin dependent diabetes 2003(03)

引证文献(1条)

1.王毅降血糖类药物研究进展[期刊论文]-中国医药指南 2008(17)

本文链接：https://www.wendangku.net/doc/c914648748.html,/Periodical_zgyyyypjyfx200501003.aspx